Literature DB >> 6831119

Stereospecific enhancement of evoked release of brain acetylcholine by narcotic antagonists.

K Jhamandas, M Sutak.   

Abstract

1--Electrical stimulation of nerves in the forepaw of anaesthetized rats caused an increase in the release of acetylcholine (ACh) from the cerebral cortex in vivo. Actions of naloxone (Nal) enantiomers and naltrexone (Ntx) were tested on this release in normal animals and those lacking pituitary gland for 3 weeks. 2--In normal animals systemic administration of (-)-Nal or Ntx, but not (+)-Nal caused a significant increase in the evoked release of ACh. Spinally administered (-)-Nal did not produce this effect. Cortical application of (-)-Nal produced a smaller increase in the evoked release of ACh. 3--In hypophysectomized rats the stimulatory action of (-)-Nal or Ntx on ACh release was significantly reduced. The ability of (-)-Nal to reverse inhibitory action of morphine or the enkephalin (FK 33,824) was not affected by hypophysectomy. 4--It is suggested that (-)-Nal and Ntx increase the stimulated release of cortical ACh by blocking the inhibitory action of an endogenous opioid at a subcortical site. An intact pituitary appears essential for a full expression of the Nal effect on evoked ACh release.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831119      PMCID: PMC2044700          DOI: 10.1111/j.1476-5381.1983.tb09408.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Studies on the direct spinal action of narcotics in the production of analgesia in the rat.

Authors:  T L Yaksh; T A Rudy
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

2.  Stereospecific increase by narcotic antagonists of evoked acetylcholine output in guinea-pig ileum.

Authors:  A A Waterfield; H W Kosterlitz
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

3.  Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors.

Authors:  L Terenius
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

4.  Enkephalin effects on release of brain acetylcholine.

Authors:  K Jhamandas; J Sawynok; M Sutak
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

5.  beta endorphin inhibits ACh turnover in nuclei of rat brain.

Authors:  F Moroni; D L Cheney; E Costa
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

6.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

7.  Comparative effects of opiate agonists methadone, levorphanol, and their isomers on the release of cortical ACh in vivo and in vitro.

Authors:  K Jhamandas; V Hron; M Sutak
Journal:  Can J Physiol Pharmacol       Date:  1975-08       Impact factor: 2.273

8.  Morphine-naloxone interaction in the central cholinergic system: the influence of subcortical lesioning and electrical stimulation.

Authors:  K Jhamandas; M Sutak
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

9.  Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary.

Authors:  J Rossier; T M Vargo; S Minick; N Ling; F E Bloom; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli.

Authors:  R C Frederickson; V Burgis; J D Edwards
Journal:  Science       Date:  1977-11-18       Impact factor: 47.728

View more
  2 in total

1.  Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone.

Authors:  D K Rush
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Modulation of memory by post-training epinephrine: involvement of cholinergic mechanisms.

Authors:  I B Introini-Collison; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.